EXECUTIVE SUMMARY - GOLD
EXECUTIVE SUMMARY - GOLD
EXECUTIVE SUMMARY - GOLD
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
73. American Medical Association. Guidelines<br />
for the diagnosis and treatment of nicotine<br />
dependence: how to help patients stop<br />
smoking. Washington DC: American Medical<br />
Association; 1994.<br />
74. Glynn TJ, Manley MW. How to help your<br />
patients stop smoking. A Nattional Cancer<br />
Institute manual for physicians. Bethesda,<br />
MD: US Department of Health and Human<br />
Services, Public Health Service, National<br />
Institutes of Health, National Cancer Institute;<br />
1990.<br />
75. Glynn TJ, Manley MW, Pechacek TF.<br />
Physician-initiated smoking cessation<br />
program: the National Cancer Institute trials.<br />
Prog Clin Biol Res 1990;339:11-25.<br />
76. Fiore MC, Bailey WC, Cohen SJ. Smoking<br />
cessation: information for specialists.<br />
Rockville, MD: US Department of Health and<br />
Human Services, Public Health Service,<br />
Agency for Health Care Policy and Research<br />
and Centers for Disease Control and<br />
Prevention; 1996.<br />
77. Lancaster T, Stead L, Silagy C, Sowden A.<br />
Effectiveness of interventions to help people<br />
stop smoking: findings from the Cochrane<br />
Library. BMJ 2000;321(7257):355-8.<br />
78. Tashkin D, Kanner R, Bailey W, Buist S,<br />
Anderson P, Nides M, et al. Smoking<br />
cessation in patients with chronic obstructive<br />
pulmonary disease: a double-blind,<br />
placebocontrolled, randomised trial. Lancet<br />
2001;357(9268):1571-5.<br />
79. Jorenby DE, Leischow SJ, Nides MA,<br />
Rennard SI, Johnston JA, Hughes AR, et al. A<br />
controlled trial of sustained-release<br />
bupropion, a nicotine patch, or both for<br />
smoking cessation. N Engl J Med<br />
1999;340(9):685-91.<br />
80. Jorenby DE, Hays JT, Rigotti NA, Axoulay S,<br />
Watsky EJ, Williams KE, et al. Efficacy of<br />
varenicline, an alpha4beta2 nicotinic<br />
acetylcholine receptor partial agonist, vs<br />
placebo or sustained-release bupropion for<br />
smoking cessation: a randomised controlled<br />
trial. JAMA 2006;296(1):56-63.<br />
81. Nides M, Oncken C, Gonzales D, Rennard S,<br />
Watsky EJ, Anziano R, et al. Smoking<br />
cessation with varenicline, a selective<br />
alpha4beta2 nicotinic receptor partial agonist:<br />
results from a 7-week, randomised, placeboand<br />
bupropion- controlled trial with 1-year<br />
follow-up. Arch Intern Med<br />
2006;166(15):1561-8.<br />
82. Tonstad S, Tonnesen P, Hajek P, Williams<br />
KE, Billing CB, Reeves KR, et al. Effect of<br />
maintenance therapy with varenicline on<br />
smoking cessation: a randomised controlled<br />
trial. JAMA 2006;296(1):64-71.<br />
83. Chapman RS, Xingzhou H, Blair AE, Lan Q.<br />
Improvement in household stoves and risk of<br />
chronic obstructive pulmonary disease in<br />
Xuanwei, China: retrospective cohort study.<br />
Br Med J 2005;331:1050.<br />
84. Ghambarian MH, Feenstra TL, Zwanikken P,<br />
Kalinina AM. Can prevention be improved?<br />
Proposal for an integrated intervention<br />
strategy. Preventive Medicine 2004;39:337-<br />
43.<br />
85. Nichter M. Introducing tobacco cessation in<br />
developing countries: an overview of Quit<br />
Tobacco International. Tobacco Control<br />
2006;15(Supplement 1):12-7.